Anlon Healthcare Ltd vs Himadri Speciality Chemical Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 30, 2026

Key Highlights

The Latest Trading Price of Anlon Healthcare Ltd is ₹ 116 as of 27 Mar 15:30 . The P/E Ratio of Anlon Healthcare Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Himadri Speciality Chemical Ltd changed from 36.9 on March 2021 to 37.7 on March 2025 . This represents a CAGR of 0.43% over 5 years The Market Cap of Anlon Healthcare Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Himadri Speciality Chemical Ltd changed from ₹ 1747 crore on March 2021 to ₹ 20929 crore on March 2025 . This represents a CAGR of 64.32% over 5 years The revenue of Anlon Healthcare Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Himadri Speciality Chemical Ltd for the Dec '25 is ₹ 1230 crore as compare to the Sep '25 revenue of ₹ 1106 crore. This represent the growth of 11.13% The ebitda of Anlon Healthcare Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Himadri Speciality Chemical Ltd for the Dec '25 is ₹ 289.2 crore as compare to the Sep '25 ebitda of ₹ 268.71 crore. This represent the growth of 7.63% The net profit of Anlon Healthcare Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Himadri Speciality Chemical Ltd changed from ₹ 122.78 crore to ₹ 192.04 crore over 7 quarters. This represents a CAGR of 29.12% The Dividend Payout of Anlon Healthcare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Himadri Speciality Chemical Ltd changed from 13.47 % on March 2021 to 5.31 % on March 2025 . This represents a CAGR of -16.99% over 5 years .

About Anlon Healthcare Ltd

Anlon Healthcare Limited was originally incorporated as 'Anlon Ventures Private Limited', dated November 19, 2013 issued by the RoC. The Company changed the name from 'Anlon Ventures Private Limited' to 'Anlon Healthcare Private Limited' and a fresh Certificate of Incorporation dated May 27, 2015 was issued by the RoC. The status of the Company was subsequently converted to a Public Limited and the name of the Company was changed to 'Anlon Healthcare Limited' dated September 2, 2024 by the RoC. Anlon Healthcare is engaged in manufacturing of Pharma Intermediates and APIs.
They are one of the few manufacturers of loxoprofen sodium dihydrate in India, a notable API , widely used in treatment of pain/inflammation association with conditions including rheumatoid arthritis, osteoarthritis, lower back pain, frozen shoulder, neck-shoulder-arm syndrome, tooth pain or after surgery, injury or tooth extraction.

About Himadri Speciality Chemical Ltd

Himadri Speciality Chemical Limited, formerly known as Himadri Chemicals & Industries Limited, is the flagship of Himadri Group.
The Company was incorporated on July 28, 1987, which changed to Himadri Speciality Chemical Limited in June, 2016.
The Company is primarily engaged in manufacturing of carbon materials and chemicals.
It has operations in India and caters to domestic and international markets.
It has a wholly-owned subsidiary in India in the name of AAT Global Limited, incorporated in Hong Kong and a step down subsidiary with 94% shareholding in the name of Shandong Dawn Himadri Chemical Industry Ltd, incorporated in China. The Company was founded to develop, manufacture and market chemical products with a special emphasis on coal tar and its derivatives.

FAQs for the comparison of Anlon Healthcare Ltd and Himadri Speciality Chemical Ltd

Which company has a larger market capitalization, Anlon Healthcare Ltd or Himadri Speciality Chemical Ltd?

Market cap of Anlon Healthcare Ltd is 616 Cr while Market cap of Himadri Speciality Chemical Ltd is 22,399 Cr

What are the key factors driving the stock performance of Anlon Healthcare Ltd and Himadri Speciality Chemical Ltd?

The stock performance of Anlon Healthcare Ltd and Himadri Speciality Chemical Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Anlon Healthcare Ltd and Himadri Speciality Chemical Ltd?

As of March 30, 2026, the Anlon Healthcare Ltd stock price is INR ₹116.0. On the other hand, Himadri Speciality Chemical Ltd stock price is INR ₹443.95.

How do dividend payouts of Anlon Healthcare Ltd and Himadri Speciality Chemical Ltd compare?

To compare the dividend payouts of Anlon Healthcare Ltd and Himadri Speciality Chemical Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.